STREPSILS BLOCKED NOSE lozenge blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

menthol, Quantity: 8 mg; dichlorobenzyl alcohol, Quantity: 1.2 mg; amylmetacresol, Quantity: 0.6 mg

Available from:

Reckitt Benckiser Pty Ltd

Pharmaceutical form:

Lozenge

Composition:

Excipient Ingredients: liquid glucose; indigo carmine; sucrose; tartaric acid; Eucalyptus Oil

Administration route:

Oral

Units in package:

6 lozenges, 16 lozenges, 8 lozenges, 24 lozenges, 48 lozenges, 36 lozenges

Prescription type:

Not scheduled. Not considered by committee

Therapeutic indications:

Antibacterial/antiseptic lozenge for the temporary relief of the symptoms/discomfort of sore throats and minor mouth infections, and helps clear the nose.

Product summary:

Visual Identification: Blue coloured lozenge; Container Type: Blister Pack; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

1991-09-09